RBC Capital Cuts Amrize (AMRZ) Price Target to $32

RBC Capital has maintained its Underperform rating on Amrize Ltd, lowering its price target to $32.0 on October 9, 2026, a 15.28% downside from the current price.

By EarningsIQ Research Desk · Published Oct 16, 2026, 2:20 PM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

RBC Capital cut its price target on Amrize Ltd ($AMRZ) to $32 from $48 on October 9, 2026, and rates the stock "Underperform".

Since the rating, $AMRZ is up 4.5% after 1 week and up 4.5% to date (from the $36.20 close on Oct 9, 2026).

AMRZ Amrize Ltd

$37.82 -30.92% year to date

Daily close · Oct 16, 2026

Key Points

RBC Capital reiterated its Underperform rating on Amrize Ltd and lowered its price target from $48.0 to $32.0 on October 9, 2026.
RBC Capital's $32 price target implies 15.28% downside from Amrize Ltd's ($AMRZ) current $37.77 share price.
Amrize Ltd shares recently traded at $37.77, which is about 18.0% above RBC's new price target.
Several other analysts have mixed views, with Barclays initiating coverage with an Equal-Weight rating and a $55.0 target on October 1, 2026.

Get $AMRZ trade alerts by text

We text you when insiders, Congress or big funds trade $AMRZ. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Amrize Ltd alert may contain errors. Disclosures

RBC Capital has reiterated its Underperform rating on Amrize Ltd (NYSE: AMRZ) and lowered its price target from $48.0 to $32.0 on October 9, 2026. The stock recently traded at $37.77, which is about 18.0% above the new target set by RBC Capital.

Other Institutional Activity in Amrize Ltd

Vanguard Capital Management LLC holds 21,330,317 shares of Amrize Ltd, having increased its position by 701,384 shares, valued at approximately $806.9 million. Blackrock Inc. also grew its stake by 731,523 shares, bringing its total to 16,164,491 shares worth about $611.5 million. Meanwhile, Harris Associates L.P. increased its holdings by 2,646,629 shares, ending with 13,990,945 shares valued at about $529.3 million.

Amrize Ltd Stock Up 0.6%

Amrize Ltd shares are currently trading at $37.77, above the new target set by RBC Capital. The shares are positioned well above the new price target, indicating some market confidence despite the Underperform rating.

12-month forecast

$AMRZ price target

Amrize Ltd daily closes and this analyst's $32 target. Not advice.

Recent Earnings

For the trailing twelve months, Amrize Ltd reported revenue of approximately $12.18 billion and an EPS of $2.23. The company has a net margin of 10.1% and a return on equity of 9.7%. The next earnings report is scheduled for October 27, 2026.

Insider Buying and Selling at Amrize Ltd

Insider transactions show some activity. Denise R Singleton, an Officer, purchased 3,500 shares at an average price of $44.12 on August 25, 2026, totaling about $154,402. Director Jacques Wolf Ph.D. Sanche bought 4,150 shares at $45.02 on August 26, 2026, worth about $186,833.

Analysts Set New Price Targets

On October 1, 2026, Barclays initiated coverage on Amrize Ltd with an Equal-Weight rating and a price target of $55.0. Citigroup maintained its Buy rating with a target of $50.0 on October 2, 2026, down from $58.0. Wells Fargo also maintained its Equal-Weight rating, lowering its target from $44.0 to $40.0 on October 5, 2026. Truist Securities maintained its Hold rating with a target of $35.0, down from $48.0 on the same day.

About Amrize Ltd

Amrize Ltd is based in Zug, Switzerland, and specializes in building solutions for the infrastructure and construction markets in North America and Canada. The company operates in two segments: Building Materials and Building Envelope, providing products like cement, aggregates, and ready-mix concrete. This recent analyst rating and target adjustment reflect the challenges the company faces in a competitive market.

Bottom Line

Investors should keep an eye on Amrize Ltd as it approaches its next earnings date on October 27, 2026. With RBC Capital's Underperform rating and lowered price target, the market will be watching how the stock performs against these expectations.